CEACAM5 and neoplasm: Other baseline characteristics, such as age, sex, tumour location, histological classification, PS score, peritoneal metastasis, number of metastatic lesions, familial history of tumour, history of palliative surgery, and CEA and CA19-9 levels at the initiation of first-line therapy, were not significantly different among the three groups.